Global Growth Opportunities: A Regulatory Perspective

Each company must have a responsible person in the form of a pharmacist registered with the South African Pharmacy Council to ensure adherence to medicine controls and be accountable for all technical and regulatory issues. Canada is the 10th-largest pharmaceutical market in the world; it ranks high...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical Processing
Main Author Bui-Van, Kimty
Format Trade Publication Article
LanguageEnglish
Published Rockaway Advantage Business Media 21.12.2017
Subjects
Councils
Pharmaceutical industry
Pharmacists
Product lines
Product testing
Registration
United States > US
Europe
Benelux
Africa
Tanzania
Ghana
Kenya
Mauritius
Canada
Netherlands
Latvia
Baltic states
Belgium
Luxembourg
Namibia
Botswana
Montreal Quebec Canada
South Africa
Uganda
Lithuania
Estonia
Online AccessGet full text

Cover

More Information
Summary:Each company must have a responsible person in the form of a pharmacist registered with the South African Pharmacy Council to ensure adherence to medicine controls and be accountable for all technical and regulatory issues. Canada is the 10th-largest pharmaceutical market in the world; it ranks highly for cost-effective clinical trials and medical product testing[iii]; and it is a leader in biotechnology and vaccines. Kimty Bui-Van is head of regulatory affairs and pharmaceutical services at ProductLife Group. [i] “Baltic states’ pharma markets continue to emerge from crisis,” IHS Market, 17 December 2013; https://www.ihs.com/country-industry-forecasting.html?id=1065984949. [ii] 2016 Top Markets Report Pharmaceuticals Country Case Study, Canada, International Trade Administration; http://www.trade.gov/topmarkets/pdf/Pharmaceuticals_Canada.pdf. [iii] Competitive Alternatives: KPMG’s Guide to International Business Locations Costs, 2016; https://www.competitivealternatives.com/reports/compalt2016_report_vol1_en.pdf.
ISSN:1049-9156